Healthcare Sector Stocks
The Healthcare sector has a total of 1046 stocks, with a combined market cap of $9.19 trillion, total revenue of $4.67 trillion and a weighted average PE ratio of 48.57.
Market Cap
9.19T
Revenue
4.67T
Profits
189.15B
PE Ratio
48.57
Profit Margin
4.05%
Dividend Yield
0.39%
1047 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.01T | 2.02% | 2,174,824 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 641.80B | 0.28% | 4,802,767 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 462.58B | 1.81% | 4,512,318 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 357.37B | 0.64% | 7,397,934 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 344.27B | 1.18% | 3,096,700 | 450.53B |
| 6 | NVS | Novartis AG | 264.80B | 1.33% | 2,482,496 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 254.11B | 2.25% | 3,093,638 | 61.37B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 226.88B | 0.62% | 1,271,147 | 46.34B |
| 9 | AMGN | Amgen Inc. | 206.25B | 1.10% | 1,878,939 | 38.10B |
| 10 | NVO | Novo Nordisk A/S | 191.47B | 0.88% | 6,562,790 | 50.34B |
| 11 | GILD | Gilead Sciences, Inc. | 181.54B | 1.87% | 4,920,228 | 30.46B |
| 12 | ABT | Abbott Laboratories | 178.39B | 1.12% | 7,812,653 | 46.59B |
| 13 | PFE | Pfizer Inc. | 157.99B | - | 28,543,021 | 63.70B |
| 14 | DHR | Danaher Corporation | 142.88B | 1.55% | 3,657,137 | 25.11B |
| 15 | ISRG | Intuitive Surgical, Inc. | 133.52B | 2.38% | 2,433,727 | 11.03B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 131.68B | 0.79% | 848,308 | 12.59B |
| 17 | BMY | Bristol-Myers Squibb Company | 130.94B | 0.72% | 7,047,074 | 49.19B |
| 18 | CVS | CVS Health Corporation | 122.21B | 0.94% | 4,453,426 | 412.65B |
| 19 | MDT | Medtronic plc | 119.98B | 3.12% | 9,224,366 | 37.54B |
| 20 | SYK | Stryker Corporation | 108.12B | 2.29% | 2,937,039 | 25.84B |
| 21 | MCK | McKesson Corporation | 106.21B | 3.34% | 617,627 | 410.98B |
| 22 | SNY | Sanofi | 104.29B | 1.31% | 2,327,865 | 55.89B |
| 23 | GSK | GSK plc | 100.17B | 3.99% | 3,022,966 | 44.05B |
| 24 | HCA | HCA Healthcare, Inc. | 92.12B | -0.34% | 1,305,921 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 92.00B | 1.32% | 1,127,913 | 201.11B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 79.26B | 1.57% | 642,639 | 15.53B |
| 27 | CI | The Cigna Group | 76.64B | 3.31% | 1,309,234 | 282.38B |
| 28 | BSX | Boston Scientific Corporation | 65.29B | 4.82% | 20,517,151 | 21.00B |
| 29 | ARGX | argenx SE | 62.63B | 0.62% | 223,390 | 5.32B |
| 30 | COR | Cencora, Inc. | 62.25B | 1.45% | 752,063 | 332.77B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 59.26B | 1.86% | 2,220,719 | 28.42B |
| 32 | MRNA | Moderna, Inc. | 58.56B | 1.89% | 9,218,597 | 2.23B |
| 33 | CAH | Cardinal Health, Inc. | 54.63B | 0.14% | 2,278,670 | 254.25B |
| 34 | BDX | Becton, Dickinson and Company | 49.82B | 2.85% | 1,634,140 | 22.48B |
| 35 | EW | Edwards Lifesciences Corporation | 49.29B | 1.36% | 2,991,562 | 6.51B |
| 36 | NTRA | Natera, Inc. | 49.27B | 3.91% | 1,042,831 | 2.71B |
| 37 | HUM | Humana Inc. | 48.88B | -0.68% | 708,834 | 145.68B |
| 38 | TEVA | Teva Pharmaceutical Industries Limited | 45.12B | 4.39% | 4,381,842 | 17.32B |
| 39 | RVMD | Revolution Medicines, Inc. | 43.96B | 0.66% | 1,285,590 | - |
| 40 | IQV | IQVIA Holdings Inc. | 43.73B | 1.49% | 1,279,777 | 16.98B |
| 41 | VEEV | Veeva Systems Inc. | 43.01B | 1.25% | 1,362,029 | 3.46B |
| 42 | MDLN | Medline Inc. | 42.85B | 0.18% | 4,645,149 | 29.94B |
| 43 | A | Agilent Technologies, Inc. | 41.39B | -0.09% | 1,646,740 | 7.37B |
| 44 | HLN | Haleon plc | 40.63B | 2.18% | 13,523,691 | 14.80B |
| 45 | WAT | Waters Corporation | 40.28B | 0.41% | 728,756 | 4.64B |
| 46 | ONC | BeOne Medicines AG | 40.23B | 2.11% | 273,063 | 6.13B |
| 47 | IDXX | IDEXX Laboratories, Inc. | 40.14B | 0.96% | 447,363 | 4.55B |
| 48 | CNC | Centene Corporation | 34.29B | 4.50% | 4,107,378 | 180.30B |
| 49 | RPRX | Royalty Pharma plc | 33.95B | 0.75% | 2,967,174 | 2.54B |
| 50 | ALNY | Alnylam Pharmaceuticals, Inc. | 33.45B | 0.53% | 911,570 | 4.80B |
| 51 | ALC | Alcon Inc. | 32.51B | 2.59% | 1,994,156 | 10.86B |
| 52 | BIIB | Biogen Inc. | 32.12B | 0.10% | 629,906 | 10.03B |
| 53 | DXCM | DexCom, Inc. | 31.95B | 1.99% | 2,556,475 | 4.97B |
| 54 | RMD | ResMed Inc. | 31.90B | 2.16% | 989,006 | 5.65B |
| 55 | ILMN | Illumina, Inc. | 31.44B | 0.85% | 1,982,097 | 4.49B |
| 56 | ZTS | Zoetis Inc. | 30.44B | 0.96% | 3,768,414 | 9.53B |
| 57 | ROIV | Roivant Sciences Ltd. | 29.63B | 0.49% | 7,563,477 | 7.53M |
| 58 | GEHC | GE HealthCare Technologies Inc. | 29.02B | 0.50% | 2,824,779 | 21.27B |
| 59 | INSM | Insmed Incorporated | 27.36B | -3.18% | 1,610,446 | 1.14B |
| 60 | DGX | Quest Diagnostics Incorporated | 26.26B | 1.22% | 974,845 | 11.56B |
| 61 | MTD | Mettler-Toledo International Inc. | 25.76B | -0.60% | 228,279 | 4.13B |
| 62 | LH | Labcorp Holdings Inc. | 25.57B | 1.21% | 707,835 | 14.35B |
| 63 | WST | West Pharmaceutical Services, Inc. | 25.00B | 2.59% | 629,944 | 3.33B |
| 64 | BNTX | BioNTech SE | 24.83B | 2.20% | 1,233,671 | 3.03B |
| 65 | INCY | Incyte Corporation | 24.77B | 0.59% | 1,455,840 | 5.82B |
| 66 | PHG | Koninklijke Philips N.V. | 24.43B | 1.99% | 867,510 | 20.18B |
| 67 | GH | Guardant Health, Inc. | 22.52B | 6.65% | 1,488,157 | 1.18B |
| 68 | UTHR | United Therapeutics Corporation | 21.56B | 1.12% | 605,728 | 3.15B |
| 69 | THC | Tenet Healthcare Corporation | 21.30B | 0.31% | 626,049 | 21.81B |
| 70 | STE | STERIS plc | 20.83B | 1.38% | 742,432 | 6.04B |
| 71 | GMAB | Genmab A/S | 19.52B | 0.57% | 1,411,692 | 4.13B |
| 72 | VTRS | Viatris Inc. | 19.14B | 0.91% | 7,027,337 | 14.74B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 18.41B | 3.26% | 2,032,454 | 8.51B |
| 74 | ASND | Ascendis Pharma A/S | 17.40B | 0.53% | 417,646 | 1.20B |
| 75 | MEDP | Medpace Holdings, Inc. | 16.62B | 1.34% | 206,313 | 2.78B |
| 76 | NBIX | Neurocrine Biosciences, Inc. | 15.98B | 0.64% | 778,730 | 3.37B |
| 77 | JAZZ | Jazz Pharmaceuticals plc | 15.96B | 0.03% | 465,442 | 4.60B |
| 78 | SOLV | Solventum Corporation | 15.29B | 2.71% | 816,821 | 8.31B |
| 79 | SMMT | Summit Therapeutics Inc. | 14.69B | 4.96% | 6,500,269 | - |
| 80 | RVTY | Revvity, Inc. | 14.34B | 3.36% | 1,895,178 | 2.91B |
| 81 | BBIO | BridgeBio Pharma, Inc. | 14.15B | -0.08% | 1,836,297 | 713.07M |
| 82 | EXEL | Exelixis, Inc. | 13.93B | 0.16% | 1,735,365 | 2.44B |
| 83 | CRL | Charles River Laboratories International, Inc. | 13.04B | -1.85% | 1,594,793 | 4.00B |
| 84 | ICLR | ICON Public Limited Company | 13.03B | -0.22% | 1,325,061 | 8.29B |
| 85 | BMRN | BioMarin Pharmaceutical Inc. | 12.86B | 1.11% | 1,336,298 | 3.41B |
| 86 | PEN | Penumbra, Inc. | 12.60B | 0.67% | 269,555 | 1.50B |
| 87 | BTSG | BrightSpring Health Services, Inc. | 12.56B | 2.67% | 3,449,923 | 14.37B |
| 88 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.48B | 1.04% | 156,529 | 1.28B |
| 89 | BAX | Baxter International Inc. | 12.34B | 0.25% | 5,741,918 | 11.47B |
| 90 | HALO | Halozyme Therapeutics, Inc. | 12.25B | 0.69% | 898,254 | 1.66B |
| 91 | FMS | Fresenius Medical Care AG | 12.10B | 2.28% | 646,818 | 22.19B |
| 92 | EHC | Encompass Health Corporation | 12.09B | 0.67% | 747,873 | 6.21B |
| 93 | CORT | Corcept Therapeutics Incorporated | 12.09B | -0.88% | 1,275,769 | 830.81M |
| 94 | DVA | DaVita Inc. | 12.07B | 4.28% | 702,810 | 14.01B |
| 95 | SNN | Smith & Nephew plc | 11.89B | 3.27% | 1,452,394 | 6.30B |
| 96 | ELAN | Elanco Animal Health Incorporated | 11.57B | -0.09% | 3,881,740 | 5.02B |
| 97 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.39B | -2.63% | 1,319,299 | 669.50M |
| 98 | AXSM | Axsome Therapeutics, Inc. | 11.34B | -1.89% | 718,760 | 776.57M |
| 99 | TECH | Bio-Techne Corporation | 11.33B | 0.21% | 2,740,155 | 1.22B |
| 100 | TEM | Tempus AI, Inc. | 11.22B | 5.42% | 4,720,347 | 1.43B |
| 101 | MOH | Molina Healthcare, Inc. | 11.15B | 4.82% | 678,963 | 42.47B |
| 102 | ALGN | Align Technology, Inc. | 10.87B | 1.45% | 718,575 | 4.14B |
| 103 | OSCR | Oscar Health, Inc. | 10.42B | 3.17% | 5,140,581 | 15.32B |
| 104 | COO | The Cooper Companies, Inc. | 10.31B | 0.58% | 5,400,529 | 4.24B |
| 105 | AVTR | Avantor, Inc. | 10.25B | 2.36% | 9,136,057 | 6.56B |
| 106 | KRSA | Korsana Biosciences, Inc. | 10.23B | -0.92% | 52,120 | - |
| 107 | UHS | Universal Health Services, Inc. | 10.21B | -0.90% | 610,202 | 18.11B |
| 108 | GMED | Globus Medical, Inc. | 10.17B | 2.13% | 1,350,590 | 3.14B |
| 109 | RDY | Dr. Reddy's Laboratories Limited | 10.12B | 0.08% | 2,114,201 | 3.50B |
| 110 | ENSG | The Ensign Group, Inc. | 10.11B | 0.55% | 288,764 | 5.49B |
| 111 | GKOS | Glaukos Corporation | 10.09B | 2.30% | 906,306 | 612.84M |
| 112 | CYTK | Cytokinetics, Incorporated | 10.07B | -1.79% | 1,531,944 | 67.67M |
| 113 | KRYS | Krystal Biotech, Inc. | 10.06B | -2.01% | 258,560 | 440.48M |
| 114 | ABVX | ABIVAX Société Anonyme | 10.02B | -4.27% | 1,155,599 | 5.67M |
| 115 | BIO | Bio-Rad Laboratories, Inc. | 9.85B | -0.21% | 292,988 | 2.59B |
| 116 | HSIC | Henry Schein, Inc. | 9.85B | 0.65% | 818,347 | 13.60B |
| 117 | PTGX | Protagonist Therapeutics, Inc. | 9.56B | -0.26% | 598,117 | 281.99M |
| 118 | PODD | Insulet Corporation | 9.56B | 4.43% | 2,343,476 | 3.05B |
| 119 | KYMR | Kymera Therapeutics, Inc. | 9.53B | -0.29% | 498,971 | 105.00M |
| 120 | RGEN | Repligen Corporation | 9.48B | 1.71% | 514,397 | 785.10M |
| 121 | PRAX | Praxis Precision Medicines, Inc. | 9.23B | -1.20% | 293,708 | 7.46M |
| 122 | TXG | 10x Genomics, Inc. | 9.13B | 2.22% | 3,363,062 | 616.91M |
| 123 | IBRX | ImmunityBio, Inc. | 8.87B | 5.82% | 8,153,501 | 165.79M |
| 124 | PCVX | Vaxcyte, Inc. | 8.86B | 0.12% | 1,428,381 | - |
| 125 | QGEN | Qiagen N.V. | 8.66B | -1.46% | 2,036,577 | 2.10B |
| 126 | IONS | Ionis Pharmaceuticals, Inc. | 8.55B | -5.11% | 6,153,012 | 874.09M |
| 127 | TWST | Twist Bioscience Corporation | 8.45B | 5.92% | 1,804,027 | 431.80M |
| 128 | BRKR | Bruker Corporation | 8.02B | -1.44% | 2,784,965 | 3.50B |
| 129 | SYRE | Spyre Therapeutics, Inc. | 8.01B | 0.22% | 1,101,142 | - |
| 130 | HQY | HealthEquity, Inc. | 7.94B | -0.23% | 1,087,786 | 1.36B |
| 131 | ATR | AptarGroup, Inc. | 7.94B | 0.06% | 337,951 | 3.93B |
| 132 | IMVT | Immunovant, Inc. | 7.78B | 0.80% | 1,096,165 | - |
| 133 | ALKS | Alkermes plc | 7.69B | -0.30% | 2,090,549 | 1.67B |
| 134 | TGTX | TG Therapeutics, Inc. | 7.66B | 0.20% | 1,362,118 | 799.54M |
| 135 | HNGE | Hinge Health, Inc. | 7.65B | 7.00% | 2,458,718 | 720.06M |
| 136 | CAI | Caris Life Sciences, Inc. | 7.36B | 7.03% | 3,642,173 | 989.61M |
| 137 | PACS | PACS Group, Inc. | 7.05B | -0.47% | 759,952 | 5.55B |
| 138 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.05B | -2.17% | 737,367 | 239.92M |
| 139 | BLTE | Belite Bio, Inc | 6.97B | -0.45% | 213,154 | - |
| 140 | HIMS | Hims & Hers Health, Inc. | 6.72B | 4.73% | 11,969,903 | 2.58B |
| 141 | CHE | Chemed Corporation | 6.69B | -0.33% | 105,870 | 2.60B |
| 142 | GRFS | Grifols, S.A. | 6.67B | -0.93% | 294,647 | 8.48B |
| 143 | LNTH | Lantheus Holdings, Inc. | 6.55B | 0.07% | 1,285,171 | 1.56B |
| 144 | CGON | CG Oncology, Inc. | 6.54B | 1.99% | 829,543 | 6.23M |
| 145 | ORKA | Oruka Therapeutics, Inc. | 6.35B | 3.84% | 773,832 | - |
| 146 | SRRK | Scholar Rock Holding Corporation | 6.31B | -6.42% | 4,042,725 | - |
| 147 | MIRM | Mirum Pharmaceuticals, Inc. | 6.28B | -1.50% | 488,536 | 618.07M |
| 148 | BLCO | Bausch + Lomb Corporation | 6.28B | 1.91% | 205,398 | 5.32B |
| 149 | TVTX | Travere Therapeutics, Inc. | 6.20B | -0.57% | 924,538 | 591.33M |
| 150 | MMED | MiniMed Group, Inc. | 6.18B | -2.36% | 4,386,491 | 3.22B |
| 151 | DNTH | Dianthus Therapeutics, Inc. | 6.02B | 1.40% | 487,010 | 1.90M |
| 152 | AMRX | Amneal Pharmaceuticals, Inc. | 6.00B | 1.23% | 1,628,496 | 3.12B |
| 153 | KNSA | Kiniksa Pharmaceuticals International, plc | 5.98B | 0.41% | 447,104 | 840.85M |
| 154 | RDNT | RadNet, Inc. | 5.94B | - | 1,177,374 | 2.27B |
| 155 | LQDA | Liquidia Corporation | 5.85B | -2.15% | 1,074,340 | 450.91M |
| 156 | STVN | Stevanato Group S.p.A. | 5.82B | 2.01% | 236,571 | 1.40B |
| 157 | COGT | Cogent Biosciences, Inc. | 5.80B | - | 1,434,323 | - |
| 158 | ERAS | Erasca, Inc. | 5.65B | 1.76% | 2,362,344 | - |
| 159 | XENE | Xenon Pharmaceuticals Inc. | 5.64B | -0.78% | 408,952 | 7.50M |
| 160 | LGND | Ligand Pharmaceuticals Incorporated | 5.59B | -1.34% | 158,766 | 290.54M |
| 161 | PTCT | PTC Therapeutics, Inc. | 5.55B | 0.64% | 1,018,791 | 1.01B |
| 162 | TFX | Teleflex Incorporated | 5.52B | -0.53% | 987,019 | 2.25B |
| 163 | DFTX | Definium Therapeutics, Inc. | 5.41B | 3.50% | 7,254,036 | - |
| 164 | SHC | Sotera Health Company | 5.29B | 0.82% | 1,573,519 | 1.22B |
| 165 | MMSI | Merit Medical Systems, Inc. | 5.20B | 0.76% | 395,502 | 1.58B |
| 166 | CRSP | CRISPR Therapeutics AG | 5.12B | 2.40% | 1,520,565 | 13.39M |
| 167 | LFST | LifeStance Health Group, Inc. | 5.11B | 3.16% | 5,241,118 | 1.58B |
| 168 | EWTX | Edgewise Therapeutics, Inc. | 4.85B | 0.50% | 1,199,274 | - |
| 169 | HAE | Haemonetics Corporation | 4.84B | 3.53% | 894,742 | 1.35B |
| 170 | WAY | Waystar Holding Corp. | 4.77B | 6.09% | 3,163,103 | 1.21B |
| 171 | ACAD | ACADIA Pharmaceuticals Inc. | 4.74B | -1.11% | 1,628,470 | 1.14B |
| 172 | DOCS | Doximity, Inc. | 4.70B | 3.17% | 2,406,821 | 655.57M |
| 173 | BLLN | BillionToOne, Inc. | 4.66B | 2.08% | 420,203 | 397.41M |
| 174 | CON | Concentra Group Holdings Parent, Inc. | 4.57B | 2.46% | 871,230 | 2.29B |
| 175 | PBLS | Parabilis Medicines, Inc. | 4.47B | -1.95% | 482,347 | 148.00K |
| 176 | LIVN | LivaNova PLC | 4.44B | 3.13% | 552,034 | 1.47B |
| 177 | HTFL | HeartFlow, Inc. | 4.31B | -0.68% | 1,619,526 | 212.07M |
| 178 | ITGR | Integer Holdings Corporation | 4.29B | 0.10% | 708,759 | 1.84B |
| 179 | MANE | Veradermics, Incorporated | 4.25B | 2.76% | 620,660 | - |
| 180 | AMLX | Amylyx Pharmaceuticals, Inc. | 4.22B | 6.39% | 1,816,909 | -665.00K |
| 181 | IOVA | Iovance Biotherapeutics, Inc. | 4.19B | 7.67% | 21,035,127 | 324.97M |
| 182 | RLAY | Relay Therapeutics, Inc. | 4.18B | 1.01% | 2,400,234 | 10.35M |
| 183 | NVST | Envista Holdings Corporation | 4.14B | 0.94% | 2,062,629 | 2.86B |
| 184 | TNGX | Tango Therapeutics, Inc. | 4.14B | 3.20% | 2,010,818 | 53.81M |
| 185 | CELC | Celcuity Inc. | 4.09B | 0.10% | 1,644,782 | - |
| 186 | INDV | Indivior Pharmaceuticals, Inc. | 4.07B | -0.06% | 4,609,442 | 1.33B |
| 187 | ELVN | Enliven Therapeutics, Inc. | 3.99B | 0.20% | 855,527 | - |
| 188 | TLX | Telix Pharmaceuticals Limited | 3.96B | 4.34% | 629,154 | 890.79M |
| 189 | ADPT | Adaptive Biotechnologies Corporation | 3.95B | 2.40% | 1,730,340 | 308.08M |
| 190 | ICUI | ICU Medical, Inc. | 3.94B | 0.72% | 189,865 | 2.16B |
| 191 | PLSE | Pulse Biosciences, Inc. | 3.87B | 2.07% | 505,739 | 1.19M |
| 192 | IRTC | iRhythm Holdings, Inc. | 3.78B | 2.95% | 606,280 | 825.34M |
| 193 | VKTX | Viking Therapeutics, Inc. | 3.68B | -1.41% | 1,846,935 | - |
| 194 | IDYA | IDEAYA Biosciences, Inc. | 3.67B | 1.17% | 524,738 | 234.13M |
| 195 | ABCL | AbCellera Biologics Inc. | 3.62B | 2.57% | 4,446,733 | 66.17M |
| 196 | OPCH | Option Care Health, Inc. | 3.59B | 2.17% | 1,560,938 | 5.69B |
| 197 | LEGN | Legend Biotech Corporation | 3.59B | -0.59% | 4,905,059 | 1.27B |
| 198 | OGN | Organon & Co. | 3.58B | 0.07% | 1,251,672 | 6.13B |
| 199 | NHC | National HealthCare Corporation | 3.57B | 1.47% | 53,985 | 1.56B |
| 200 | TARS | Tarsus Pharmaceuticals, Inc. | 3.51B | 0.81% | 442,756 | 606.33M |
| 201 | DYN | Dyne Therapeutics, Inc. | 3.46B | 1.70% | 3,193,545 | - |
| 202 | DNLI | Denali Therapeutics Inc. | 3.39B | 0.62% | 1,071,248 | 3.60M |
| 203 | GRAL | GRAIL, Inc. | 3.37B | -0.92% | 1,121,483 | 165.26M |
| 204 | VCYT | Veracyte, Inc. | 3.31B | 0.83% | 1,032,465 | 561.90M |
| 205 | WRBY | Warby Parker Inc. | 3.18B | 4.05% | 3,386,037 | 911.61M |
| 206 | AVAH | Aveanna Healthcare Holdings Inc. | 3.14B | 2.13% | 2,585,106 | 2.60B |
| 207 | QURE | uniQure N.V. | 3.12B | 0.94% | 637,909 | 18.67M |
| 208 | CLDX | Celldex Therapeutics, Inc. | 3.08B | 6.18% | 999,055 | 158.00K |
| 209 | RCUS | Arcus Biosciences, Inc. | 3.06B | -2.11% | 1,720,778 | 117.00M |
| 210 | ARQT | Arcutis Biotherapeutics, Inc. | 3.05B | 1.61% | 1,990,621 | 463.98M |
| 211 | TMDX | TransMedics Group, Inc. | 2.98B | 4.48% | 943,372 | 668.47M |
| 212 | GRDN | Guardian Pharmacy Services, Inc. | 2.94B | 6.53% | 925,863 | 1.46B |
| 213 | MBX | MBX Biosciences, Inc. | 2.87B | 0.80% | 323,652 | - |
| 214 | RGC | Regencell Bioscience Holdings Limited | 2.84B | 1.77% | 72,736 | - |
| 215 | BKD | Brookdale Senior Living Inc. | 2.84B | -1.89% | 2,521,908 | 2.93B |
| 216 | ATRC | AtriCure, Inc. | 2.84B | 2.29% | 1,154,685 | 569.62M |
| 217 | IMNM | Immunome, Inc. | 2.79B | -0.49% | 744,599 | 4.02M |
| 218 | ZLAB | Zai Lab Limited | 2.76B | 1.82% | 1,159,814 | 449.61M |
| 219 | GPCR | Structure Therapeutics Inc. | 2.74B | -0.57% | 1,911,769 | - |
| 220 | PHVS | Pharvaris N.V. | 2.73B | 2.21% | 997,912 | - |
| 221 | CDNA | CareDx, Inc. | 2.71B | 4.20% | 795,179 | 458.09M |
| 222 | CLOV | Clover Health Investments, Corp. | 2.71B | 5.81% | 5,483,944 | 2.48B |
| 223 | ALHC | Alignment Healthcare, Inc. | 2.68B | 2.62% | 5,666,567 | 4.58B |
| 224 | WGS | GeneDx Holdings Corp. | 2.68B | 5.25% | 532,959 | 454.43M |
| 225 | NAMS | NewAmsterdam Pharma Company N.V. | 2.67B | -1.93% | 1,078,981 | 7.12M |
| 226 | PRVA | Privia Health Group, Inc. | 2.67B | 2.25% | 1,367,412 | 2.36B |
| 227 | NRIX | Nurix Therapeutics, Inc. | 2.65B | 1.67% | 1,330,847 | 36.77M |
| 228 | IRON | Disc Medicine, Inc. | 2.65B | -1.63% | 693,958 | - |
| 229 | ACHC | Acadia Healthcare Company, Inc. | 2.61B | -1.27% | 1,081,834 | 3.37B |
| 230 | NEOG | Neogen Corporation | 2.61B | 1.44% | 1,833,317 | 870.40M |
| 231 | AXGN | Axogen, Inc. | 2.57B | 3.84% | 1,668,212 | 251.17M |
| 232 | MLYS | Mineralys Therapeutics, Inc. | 2.56B | 2.66% | 1,192,931 | - |
| 233 | VRDN | Viridian Therapeutics, Inc. | 2.52B | 4.52% | 1,300,759 | 71.13M |
| 234 | VERA | Vera Therapeutics, Inc. | 2.45B | -2.85% | 1,705,877 | - |
| 235 | PGEN | Precigen, Inc. | 2.45B | - | 2,825,497 | 85.72M |
| 236 | HRMY | Harmony Biosciences Holdings, Inc. | 2.42B | 0.05% | 892,818 | 959.90M |
| 237 | SUPN | Supernus Pharmaceuticals, Inc. | 2.41B | -0.36% | 678,058 | 830.44M |
| 238 | BEAM | Beam Therapeutics Inc. | 2.41B | 0.54% | 1,458,363 | 156.04M |
| 239 | SLS | SELLAS Life Sciences Group, Inc. | 2.37B | 1.56% | 10,533,852 | - |
| 240 | NEO | NeoGenomics, Inc. | 2.37B | 6.29% | 1,193,977 | 766.30M |
| 241 | OCUL | Ocular Therapeutix, Inc. | 2.35B | 2.19% | 1,622,980 | 52.06M |
| 242 | NKTR | Nektar Therapeutics | 2.34B | -1.81% | 1,221,546 | 54.59M |
| 243 | HCM | HUTCHMED (China) Limited | 2.33B | 6.55% | 114,602 | 549.12M |
| 244 | TRVI | Trevi Therapeutics, Inc. | 2.26B | -0.06% | 1,062,473 | - |
| 245 | PBH | Prestige Consumer Healthcare Inc. | 2.26B | 1.43% | 423,666 | 1.10B |
| 246 | TRLV | Trulieve Cannabis Corp. | 2.24B | 2.74% | 1,597,086 | 1.14B |
| 247 | BHC | Bausch Health Companies Inc. | 2.21B | 1.02% | 5,204,176 | 10.85B |
| 248 | SRPT | Sarepta Therapeutics, Inc. | 2.21B | 2.30% | 2,192,857 | 1.97B |
| 249 | PVLA | Palvella Therapeutics, Inc. | 2.19B | 1.04% | 223,046 | - |
| 250 | AUPH | Aurinia Pharmaceuticals Inc. | 2.18B | 1.93% | 753,422 | 311.51M |
| 251 | UFPT | UFP Technologies, Inc. | 2.15B | 0.04% | 90,740 | 631.64M |
| 252 | INSP | Inspire Medical Systems, Inc. | 2.15B | 1.81% | 1,172,091 | 898.74M |
| 253 | ADUS | Addus HomeCare Corporation | 2.15B | 0.20% | 197,398 | 1.48B |
| 254 | ESTA | Establishment Labs Holdings Inc. | 2.14B | 1.38% | 310,414 | 245.82M |
| 255 | PGNY | Progyny, Inc. | 2.14B | 1.83% | 570,183 | 1.31B |
| 256 | MD | Pediatrix Medical Group, Inc. | 2.13B | 0.52% | 750,867 | 1.95B |
| 257 | RAPP | Rapport Therapeutics, Inc. | 2.11B | 0.87% | 196,924 | 20.00M |
| 258 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.10B | 1.35% | 5,096,669 | 940.61M |
| 259 | NUVB | Nuvation Bio Inc. | 2.09B | -2.14% | 10,029,905 | 169.90M |
| 260 | URGN | UroGen Pharma Ltd. | 2.08B | 0.78% | 537,924 | 188.73M |
| 261 | ZBIO | Zenas BioPharma, Inc. | 2.08B | 2.54% | 634,637 | 1.00M |
| 262 | KOD | Kodiak Sciences Inc. | 2.08B | 0.76% | 547,787 | - |
| 263 | XRAY | DENTSPLY SIRONA Inc. | 2.07B | -0.76% | 3,212,734 | 3.64B |
| 264 | GENB | Generate Biomedicines, Inc. | 2.05B | 1.78% | 1,533,398 | 26.48M |
| 265 | ADMA | ADMA Biologics, Inc. | 2.05B | -0.98% | 3,067,122 | 512.28M |
| 266 | VCEL | Vericel Corporation | 2.03B | 3.29% | 615,243 | 306.30M |
| 267 | ASTH | Astrana Health, Inc. | 2.03B | 4.27% | 321,264 | 3.84B |
| 268 | CMPS | COMPASS Pathways plc | 2.01B | 1.32% | 2,512,638 | - |
| 269 | AGIO | Agios Pharmaceuticals, Inc. | 1.98B | -1.13% | 762,208 | 98.34M |
| 270 | BFLY | Butterfly Network, Inc. | 1.97B | 1.09% | 3,076,280 | 112.14M |
| 271 | MESO | Mesoblast Limited | 1.96B | -2.97% | 173,208 | 120.25M |
| 272 | ALMR | Alamar Biosciences, Inc. | 1.94B | 0.36% | 389,338 | 100.42M |
| 273 | GHRS | GH Research PLC | 1.91B | 2.54% | 126,430 | - |
| 274 | STOK | Stoke Therapeutics, Inc. | 1.91B | 1.96% | 439,858 | 27.59M |
| 275 | BHVN | Biohaven Ltd. | 1.91B | -0.55% | 1,648,658 | - |
| 276 | ZYME | Zymeworks Inc. | 1.91B | 2.32% | 563,582 | 37.13M |
| 277 | PRGO | Perrigo Company plc | 1.89B | -0.07% | 1,925,219 | 4.14B |
| 278 | COAG | Hemab Therapeutics Holdings, Inc. | 1.89B | 2.72% | 459,392 | - |
| 279 | NVCR | NovoCure Limited | 1.89B | 4.58% | 1,049,166 | 699.19M |
| 280 | SNDA | Sonida Senior Living, Inc. | 1.89B | 0.78% | 277,504 | 481.07M |
| 281 | LMAT | LeMaitre Vascular, Inc. | 1.85B | 0.22% | 247,904 | 262.43M |
| 282 | SEPN | Septerna, Inc. | 1.85B | 2.70% | 356,010 | 98.88M |
| 283 | RXRX | Recursion Pharmaceuticals, Inc. | 1.83B | 6.56% | 15,908,791 | 54.86M |
| 284 | NBTX | Nanobiotix S.A. | 1.82B | -3.46% | 128,502 | 38.27M |
| 285 | XNCR | Xencor, Inc. | 1.82B | 0.49% | 858,320 | 104.97M |
| 286 | VIR | Vir Biotechnology, Inc. | 1.82B | 1.37% | 1,841,510 | 303.23M |
| 287 | SGRY | Surgery Partners, Inc. | 1.82B | -2.36% | 2,162,268 | 3.37B |
| 288 | ALVO | Alvotech | 1.80B | -4.54% | 674,170 | 494.61M |
| 289 | KARD | Kardigan, Inc. | 1.78B | 3.02% | 806,572 | - |
| 290 | KLRA | Kailera Therapeutics, Inc. | 1.78B | -1.36% | 872,425 | - |
| 291 | DMRA | Damora Therapeutics, Inc. | 1.75B | 1.03% | 370,950 | - |
| 292 | LKFT | Lakefront Biotherapeutics NV | 1.75B | -0.37% | 249,309 | 1.13B |
| 293 | PSNL | Personalis, Inc. | 1.74B | 0.49% | 1,690,001 | 69.67M |
| 294 | BRVE | Braveheart Bio, Inc. | 1.74B | 1.76% | 209,181 | - |
| 295 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.74B | 2.37% | 2,639,451 | 208.78M |
| 296 | BLFS | BioLife Solutions, Inc. | 1.73B | 1.37% | 534,052 | 106.69M |
| 297 | ATEC | Alphatec Holdings, Inc. | 1.68B | 2.65% | 4,174,959 | 815.05M |
| 298 | IMCR | Immunocore Holdings plc | 1.67B | -0.26% | 318,385 | 430.78M |
| 299 | NTLA | Intellia Therapeutics, Inc. | 1.66B | 1.11% | 2,598,240 | 59.51M |
| 300 | FTRE | Fortrea Holdings Inc. | 1.66B | 1.22% | 2,430,280 | 2.68B |
| 301 | ETON | Eton Pharmaceuticals, Inc. | 1.65B | 0.95% | 340,906 | 105.60M |
| 302 | SNDX | Syndax Pharmaceuticals, Inc. | 1.64B | 0.94% | 1,142,335 | 252.25M |
| 303 | TSHA | Taysha Gene Therapies, Inc. | 1.63B | -0.20% | 7,909,024 | 5.49M |
| 304 | INBX | Inhibrx Biosciences, Inc. | 1.63B | 1.10% | 239,991 | 1.30M |
| 305 | FRNM | Freenome, Inc. | 1.61B | 4.11% | 755,692 | 35.41M |
| 306 | ANAB | AnaptysBio, Inc. | 1.60B | 0.45% | 436,841 | 232.39M |
| 307 | NVAX | Novavax, Inc. | 1.58B | 1.80% | 2,717,039 | 413.80M |
| 308 | SDGR | Schrödinger, Inc. | 1.55B | 9.10% | 1,951,069 | 259.04M |
| 309 | ARDT | Ardent Health, Inc. | 1.55B | 0.18% | 396,838 | 6.41B |
| 310 | AGL | agilon health, inc. | 1.55B | 2.91% | 195,043 | 5.92B |
| 311 | AVLN | Avalyn Pharma Inc. | 1.55B | 4.20% | 494,137 | - |
| 312 | BCAX | Bicara Therapeutics Inc. | 1.54B | 1.71% | 426,337 | - |
| 313 | OMCL | Omnicell, Inc. | 1.53B | 2.20% | 395,729 | 1.25B |
| 314 | HCSG | Healthcare Services Group, Inc. | 1.51B | 0.27% | 482,622 | 1.86B |
| 315 | INVA | Innoviva, Inc. | 1.51B | 1.16% | 1,110,110 | 440.00M |
| 316 | ANIP | ANI Pharmaceuticals, Inc. | 1.51B | 0.30% | 399,849 | 978.38M |
| 317 | AAPG | Ascentage Pharma Group International | 1.50B | 1.93% | 3,805 | 94.61M |
| 318 | LTGO | Latigo Biotherapeutics, Inc. | 1.50B | 2.21% | 164,838 | - |
| 319 | TYRA | Tyra Biosciences, Inc. | 1.50B | 13.80% | 2,066,090 | - |
| 320 | NUTX | Nutex Health Inc. | 1.49B | 8.38% | 244,108 | 846.72M |
| 321 | INNV | InnovAge Holding Corp. | 1.47B | 0.19% | 211,134 | 989.71M |
| 322 | PAHC | Phibro Animal Health Corporation | 1.46B | 0.90% | 258,357 | 1.52B |
| 323 | LBRX | LB Pharmaceuticals Inc | 1.45B | 0.47% | 242,770 | - |
| 324 | KMTS | Kestra Medical Technologies, Ltd. | 1.41B | 5.30% | 745,483 | 95.13M |
| 325 | AVBP | ArriVent BioPharma, Inc. | 1.41B | -1.48% | 538,336 | - |
| 326 | AZTA | Azenta, Inc. | 1.40B | 3.86% | 734,377 | 613.81M |
| 327 | PNTG | The Pennant Group, Inc. | 1.40B | 2.32% | 267,279 | 1.10B |
| 328 | CNMD | CONMED Corporation | 1.39B | 0.17% | 250,530 | 1.37B |
| 329 | ABSI | Absci Corporation | 1.39B | -1.46% | 2,426,666 | 1.56M |
| 330 | XERS | Xeris Biopharma Holdings, Inc. | 1.38B | 1.61% | 1,267,611 | 335.41M |
| 331 | MAZE | Maze Therapeutics, Inc. | 1.37B | 0.28% | 589,271 | 20.00M |
| 332 | VOR | Vor Biopharma Inc. | 1.37B | 3.50% | 887,616 | - |
| 333 | SVRA | Savara Inc. | 1.36B | 0.75% | 1,310,099 | - |
| 334 | TRAX | First Tracks Biotherapeutics, Inc. | 1.34B | 3.10% | 488,122 | - |
| 335 | RARE | Ultragenyx Pharmaceutical Inc. | 1.34B | -4.83% | 5,896,757 | 717.00M |
| 336 | SPTX | Seaport Therapeutics, Inc. | 1.33B | 6.56% | 174,186 | - |
| 337 | DRTS | Alpha Tau Medical Ltd. | 1.33B | -0.21% | 386,684 | - |
| 338 | AMN | AMN Healthcare Services, Inc. | 1.32B | 2.55% | 523,664 | 3.43B |
| 339 | CGEM | Cullinan Therapeutics, Inc. | 1.31B | -0.92% | 1,415,351 | - |
| 340 | ORIC | ORIC Pharmaceuticals, Inc. | 1.31B | 5.07% | 1,618,195 | - |
| 341 | AKTS | Aktis Oncology, Inc. | 1.29B | -0.56% | 330,074 | 10.06M |
| 342 | HROW | Harrow, Inc. | 1.28B | -1.19% | 524,008 | 275.59M |
| 343 | OMER | Omeros Corporation | 1.26B | -4.49% | 1,688,093 | 38.42M |
| 344 | OMDA | Omada Health, Inc. | 1.25B | 4.27% | 996,935 | 309.76M |
| 345 | ANRO | Alto Neuroscience, Inc. | 1.24B | -1.00% | 453,306 | - |
| 346 | MGTX | MeiraGTx Holdings plc | 1.24B | 0.70% | 492,244 | 397.50M |
| 347 | REPL | Replimune Group, Inc. | 1.24B | 1.47% | 2,350,704 | - |
| 348 | IART | Integra LifeSciences Holdings Corporation | 1.22B | 1.35% | 1,108,678 | 1.65B |
| 349 | CERT | Certara, Inc. | 1.22B | 5.96% | 1,696,225 | 421.75M |
| 350 | AORT | Artivion, Inc. | 1.22B | -0.44% | 599,019 | 471.47M |
| 351 | GDRX | GoodRx Holdings, Inc. | 1.21B | 5.01% | 1,018,351 | 785.23M |
| 352 | MNKD | MannKind Corporation | 1.21B | - | 2,598,660 | 393.63M |
| 353 | PRCT | PROCEPT BioRobotics Corporation | 1.20B | 3.14% | 1,682,733 | 337.34M |
| 354 | USPH | U.S. Physical Therapy, Inc. | 1.20B | 2.29% | 195,413 | 804.27M |
| 355 | CRON | Cronos Group Inc. | 1.20B | 3.03% | 906,888 | 179.09M |
| 356 | ALMS | Alumis Inc. | 1.19B | 0.44% | 4,027,047 | 7.40M |
| 357 | GLUE | Monte Rosa Therapeutics, Inc. | 1.19B | -1.21% | 1,746,518 | 28.73M |
| 358 | TDOC | Teladoc Health, Inc. | 1.18B | 5.52% | 3,469,633 | 2.49B |
| 359 | SLBT | SL Science Holding Limited | 1.18B | 0.49% | 315,266 | 3.27M |
| 360 | IMTX | Immatics N.V. | 1.18B | -1.93% | 378,590 | 47.65M |
| 361 | TNDM | Tandem Diabetes Care, Inc. | 1.17B | -1.75% | 2,201,455 | 1.04B |
| 362 | OPK | OPKO Health, Inc. | 1.16B | -0.64% | 2,147,099 | 587.90M |
| 363 | ODTX | Odyssey Therapeutics, Inc. | 1.16B | -1.50% | 218,958 | 99.00K |
| 364 | STAA | STAAR Surgical Company | 1.16B | 1.81% | 798,064 | 339.59M |
| 365 | JBIO | Jade Biosciences, Inc. | 1.16B | 1.62% | 829,513 | - |
| 366 | ATTO | Attovia Therapeutics, Inc. | 1.12B | 7.59% | 286,052 | 1.80M |
| 367 | OBX | Obsidian Therapeutics, Inc. | 1.12B | 1.69% | 455,456 | - |
| 368 | BVS | Bioventus Inc. | 1.11B | 1.39% | 249,417 | 581.85M |
| 369 | CRVS | Corvus Pharmaceuticals, Inc. | 1.10B | 1.55% | 874,334 | - |
| 370 | LMRI | Lumexa Imaging Holdings, Inc. | 1.09B | -0.87% | 320,782 | 1.04B |
| 371 | MLTX | MoonLake Immunotherapeutics | 1.08B | 1.36% | 2,254,191 | - |
| 372 | APMD | Apnimed, Inc. | 1.06B | -2.59% | 263,415 | 115.12M |
| 373 | JANX | Janux Therapeutics, Inc. | 1.06B | 1.23% | 869,760 | 24.00M |
| 374 | IRMD | IRADIMED CORPORATION | 1.06B | 0.38% | 69,523 | 86.34M |
| 375 | ENOV | Enovis Corporation | 1.05B | -5.50% | 2,477,239 | 2.30B |
| 376 | GMRS | GMR Solutions Inc. | 1.03B | 3.76% | 550,063 | 5.88B |
| 377 | KURA | Kura Oncology, Inc. | 1.03B | 1.49% | 1,457,585 | 77.23M |
| 378 | ANL | Adlai Nortye Group Ltd. | 1.03B | 4.73% | 175,550 | 18.06M |
| 379 | CSTL | Castle Biosciences, Inc. | 1.02B | 3.43% | 165,373 | 357.28M |
| 380 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.02B | 0.55% | 474,862 | 730.02M |
| 381 | ABUS | Arbutus Biopharma Corporation | 1.01B | 0.20% | 3,803,256 | 181.72M |
| 382 | FTH | Faeth Therapeutics, Inc. | 1.01B | 4.41% | 265,785 | - |
| 383 | HELP | Cybin Inc. | 994.35M | 4.93% | 1,615,497 | - |
| 384 | PCRX | Pacira BioSciences, Inc. | 983.79M | -2.68% | 419,136 | 746.16M |
| 385 | SGP | SpyGlass Pharma, Inc. | 958.62M | 4.14% | 130,170 | - |
| 386 | SANA | Sana Biotechnology, Inc. | 957.95M | 2.24% | 2,380,831 | - |
| 387 | SLDB | Solid Biosciences Inc. | 937.15M | 0.46% | 1,025,184 | - |
| 388 | CBLL | CeriBell, Inc. | 933.74M | 2.96% | 280,503 | 101.96M |
| 389 | IVA | Inventiva S.A. | 928.49M | -3.48% | 1,493,402 | 7.94M |
| 390 | WVE | Wave Life Sciences, Inc. | 902.48M | -0.22% | 2,869,840 | 65.37M |
| 391 | OLMA | Olema Pharmaceuticals, Inc. | 900.35M | 0.68% | 1,822,822 | - |
| 392 | TBPH | Theravance Biopharma, Inc. | 884.18M | 0.12% | 243,260 | 104.31M |
| 393 | LXRX | Lexicon Pharmaceuticals, Inc. | 881.01M | -1.00% | 1,773,779 | 41.47M |
| 394 | GERN | Geron Corporation | 880.19M | 1.48% | 16,978,486 | 204.56M |
| 395 | ARDX | Ardelyx, Inc. | 877.14M | -1.68% | 4,364,454 | 450.89M |
| 396 | IMMX | Immix Biopharma, Inc. | 873.50M | 0.58% | 1,079,527 | - |
| 397 | AVTX | Avalo Therapeutics, Inc. | 867.73M | 0.37% | 908,327 | 59.00K |
| 398 | HSTM | HealthStream, Inc. | 866.38M | 1.79% | 173,966 | 321.12M |
| 399 | INMD | InMode Ltd. | 855.89M | -0.07% | 249,841 | 374.63M |
| 400 | AVR | Anteris Technologies Global Corp. | 849.84M | 4.43% | 551,837 | 2.24M |
| 401 | RIGL | Rigel Pharmaceuticals, Inc. | 847.13M | -4.00% | 335,724 | 276.79M |
| 402 | DSGN | Design Therapeutics, Inc. | 846.10M | -7.59% | 1,255,451 | - |
| 403 | CBIO | Crescent Biopharma, Inc. | 842.32M | 1.39% | 251,175 | 11.88M |
| 404 | SIBN | SI-BONE, Inc. | 838.11M | 1.74% | 550,951 | 213.60M |
| 405 | CLYM | Climb Bio, Inc. | 836.27M | 2.18% | 1,094,427 | - |
| 406 | ACRS | Aclaris Therapeutics, Inc. | 830.20M | 6.02% | 5,838,379 | 8.22M |
| 407 | CADL | Candel Therapeutics, Inc. | 816.84M | 1.23% | 940,801 | - |
| 408 | SLN | Silence Therapeutics plc | 786.33M | 0.31% | 1,045,190 | 615.00K |
| 409 | AHCO | AdaptHealth Corp. | 784.45M | -2.97% | 3,721,426 | 3.36B |
| 410 | VREX | Varex Imaging Corporation | 778.05M | - | 556,370 | 865.00M |
| 411 | PHAR | Pharming Group N.V. | 764.06M | -3.48% | 19,681 | 366.48M |
| 412 | GLAS | Glass House Brands Inc. | 763.36M | 2.14% | 880,548 | 176.98M |
| 413 | QDEL | QuidelOrtho Corporation | 762.56M | -5.60% | 2,335,207 | 2.67B |
| 414 | NVCT | Nuvectis Pharma, Inc. | 760.78M | -2.67% | 203,423 | - |
| 415 | FDMT | 4D Molecular Therapeutics, Inc. | 760.16M | 4.48% | 970,156 | 92.01M |
| 416 | BBNX | Beta Bionics, Inc. | 752.68M | 0.97% | 1,805,538 | 119.01M |
| 417 | ANNX | Annexon, Inc. | 748.84M | 0.25% | 2,896,023 | - |
| 418 | ACHV | Achieve Life Sciences, Inc. | 743.99M | 2.41% | 1,430,325 | - |
| 419 | COLL | Collegium Pharmaceutical, Inc. | 742.59M | 0.26% | 826,360 | 808.21M |
| 420 | DBVT | DBV Technologies S.A. | 733.56M | 4.22% | 269,583 | 5.04M |
| 421 | MPLT | MapLight Therapeutics, Inc. | 730.82M | 1.15% | 327,550 | - |
| 422 | MNPR | Monopar Therapeutics Inc. | 727.06M | -1.76% | 106,566 | - |
| 423 | AURA | Aura Biosciences, Inc. | 726.97M | 0.21% | 467,410 | - |
| 424 | ZVRA | Zevra Therapeutics, Inc. | 715.57M | 0.33% | 629,155 | 136.07M |
| 425 | GYRE | Gyre Therapeutics, Inc. | 709.37M | -0.59% | 104,117 | 109.82M |
| 426 | NGNE | Neurogene Inc. | 704.60M | -0.76% | 194,665 | 925.00K |
| 427 | CTMX | CytomX Therapeutics, Inc. | 697.28M | -2.74% | 6,131,823 | 18.30M |
| 428 | PHAT | Phathom Pharmaceuticals, Inc. | 689.45M | 3.83% | 1,315,798 | 239.66M |
| 429 | IRWD | Ironwood Pharmaceuticals, Inc. | 689.05M | 2.21% | 1,252,646 | 389.32M |
| 430 | AHG | Akso Health Group | 686.91M | -4.46% | 7,534 | 13.83M |
| 431 | VSTM | Verastem, Inc. | 680.13M | 2.60% | 1,514,527 | 87.53M |
| 432 | SSII | SS Innovations International, Inc. | 678.30M | 2.27% | 96,634 | 52.40M |
| 433 | MDXG | MiMedx Group, Inc. | 676.33M | 1.53% | 888,918 | 355.17M |
| 434 | SGMT | Sagimet Biosciences Inc. | 676.29M | - | 516,686 | - |
| 435 | SOPH | SOPHiA GENETICS SA | 669.10M | -0.13% | 309,529 | 86.17M |
| 436 | BLSM | BlossomHill Therapeutics, Inc. | 666.19M | 4.22% | 254,306 | - |
| 437 | STLN | Starling Oncology, Inc. | 664.49M | 5.67% | 1,504,137 | 587.24M |
| 438 | OCS | Oculis Holding AG | 654.36M | 0.38% | 153,182 | 1.45M |
| 439 | OABI | OmniAb, Inc. | 651.35M | 10.07% | 1,599,008 | 38.46M |
| 440 | PHR | Phreesia, Inc. | 646.78M | 1.07% | 619,186 | 507.79M |
| 441 | ALT | Altimmune, Inc. | 641.91M | 0.92% | 2,077,839 | 31.00K |
| 442 | ANGO | AngioDynamics, Inc. | 641.07M | 1.57% | 389,329 | 320.17M |
| 443 | VALN | Valneva SE | 629.46M | 0.15% | 13,344 | 163.30M |
| 444 | DRUG | Bright Minds Biosciences Inc. | 628.56M | 0.32% | 42,053 | - |
| 445 | CTKB | Cytek Biosciences, Inc. | 627.82M | 4.77% | 1,165,452 | 206.71M |
| 446 | STTK | Shattuck Labs, Inc. | 622.25M | - | 821,853 | 1.00M |
| 447 | CTEV | Claritev Corporation | 617.57M | 1.28% | 126,864 | 994.67M |
| 448 | CRMD | CorMedix Inc. | 614.98M | 0.83% | 919,549 | 462.25M |
| 449 | ALLO | Allogene Therapeutics, Inc. | 614.97M | - | 7,749,699 | 4.64M |
| 450 | AQST | Aquestive Therapeutics, Inc. | 612.50M | 2.09% | 2,491,690 | 54.09M |
| 451 | AGMB | AgomAb Therapeutics NV | 604.77M | -5.97% | 86,185 | - |
| 452 | ASMB | Assembly Biosciences, Inc. | 589.64M | -2.82% | 290,472 | 74.85M |
| 453 | EVO | Evotec SE | 586.69M | -2.89% | 36,703 | 819.47M |
| 454 | WEAV | Weave Communications, Inc. | 585.59M | 0.14% | 2,125,343 | 257.79M |
| 455 | KIDS | OrthoPediatrics Corp. | 583.29M | 1.27% | 131,164 | 252.72M |
| 456 | TECX | Tectonic Therapeutic, Inc. | 580.81M | 2.27% | 145,001 | - |
| 457 | RGNX | REGENXBIO Inc. | 573.65M | 1.88% | 847,469 | 174.48M |
| 458 | DCTH | Delcath Systems, Inc. | 570.45M | 3.33% | 503,239 | 95.42M |
| 459 | FLGT | Fulgent Genetics, Inc. | 568.19M | 0.98% | 336,328 | 323.93M |
| 460 | TLRY | Tilray Brands, Inc. | 567.15M | 2.99% | 4,397,950 | 915.45M |
| 461 | PRME | Prime Medicine, Inc. | 565.74M | 1.60% | 1,616,906 | 4.07M |
| 462 | CTNM | Contineum Therapeutics, Inc. | 557.55M | - | 552,891 | - |
| 463 | SCTX | Scribe Therapeutics Inc. | 556.97M | -1.08% | 136,961 | 33.30M |
| 464 | EPRX | Eupraxia Pharmaceuticals Inc. | 555.37M | -4.16% | 431,552 | - |
| 465 | ARVN | Arvinas, Inc. | 549.24M | -0.59% | 1,471,568 | 316.70M |
| 466 | PROK | ProKidney Corp. | 547.20M | 0.56% | 952,586 | 818.00K |
| 467 | BWAY | BrainsWay Ltd. | 543.88M | -2.15% | 113,091 | 60.70M |
| 468 | OVID | Ovid Therapeutics Inc. | 535.12M | 1.86% | 1,199,226 | 1.58M |
| 469 | EOLS | Evolus, Inc. | 523.78M | 1.15% | 515,100 | 316.49M |
| 470 | AUTL | Autolus Therapeutics plc | 516.36M | 3.19% | 1,480,505 | 117.39M |
| 471 | CERS | Cerus Corporation | 513.89M | 2.41% | 1,348,312 | 221.55M |
| 472 | CAPR | Capricor Therapeutics, Inc. | 512.20M | 5.26% | 2,906,335 | 11.13M |
| 473 | TCMD | Tactile Systems Technology, Inc. | 511.26M | 0.76% | 237,655 | 350.31M |
| 474 | EIKN | Eikon Therapeutics, Inc. | 506.98M | 4.70% | 708,957 | - |
| 475 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 4.81M |
| 476 | NPCE | NeuroPace, Inc. | 500.79M | 3.92% | 125,458 | 106.99M |
| 477 | ZURA | Zura Bio Limited | 499.27M | - | 1,041,129 | - |
| 478 | IRD | Opus Genetics, Inc. | 496.68M | -1.16% | 2,550,848 | 9.86M |
| 479 | ARTV | Artiva Biotherapeutics, Inc. | 495.75M | -0.78% | 242,706 | 251.00K |
| 480 | NRC | NRC Health | 493.49M | 5.63% | 92,567 | 140.00M |
| 481 | CABA | Cabaletta Bio, Inc. | 493.38M | 6.59% | 5,752,183 | - |
| 482 | ENTX | Entera Bio Ltd. | 488.26M | -0.70% | 99,001 | 42.00K |
| 483 | KMDA | Kamada Ltd. | 474.40M | 4.92% | 286,653 | 191.85M |
| 484 | SRTA | Strata Critical Medical, Inc. | 474.18M | 3.18% | 1,150,100 | 255.98M |
| 485 | RLMD | Relmada Therapeutics, Inc. | 473.61M | -1.77% | 1,264,729 | - |
| 486 | PRLD | Prelude Therapeutics Incorporated | 472.75M | - | 275,344 | 22.42M |
| 487 | DNA | Ginkgo Bioworks Holdings, Inc. | 472.06M | 3.85% | 1,030,256 | 132.42M |
| 488 | PBYI | Puma Biotechnology, Inc. | 471.81M | 0.22% | 256,650 | 231.24M |
| 489 | SENS | Senseonics Holdings, Inc. | 467.41M | 1.49% | 567,454 | 48.55M |
| 490 | EVH | Evolent Health, Inc. | 463.54M | -2.15% | 3,494,370 | 2.10B |
| 491 | KYTX | Kyverna Therapeutics, Inc. | 457.64M | 1.93% | 533,908 | - |
| 492 | PRTA | Prothena Corporation plc | 454.85M | -0.78% | 374,871 | 54.53M |
| 493 | VOGX | Vogenx, Inc. | 451.21M | -0.89% | 106,160 | - |
| 494 | SGHT | Sight Sciences, Inc. | 447.87M | -0.12% | 120,720 | 83.38M |
| 495 | SPRY | ARS Pharmaceuticals, Inc. | 447.51M | -5.46% | 2,166,698 | 116.93M |
| 496 | RZLT | Rezolute, Inc. | 443.98M | 0.71% | 828,016 | - |
| 497 | IKT | Inhibikase Therapeutics, Inc. | 435.16M | 2.14% | 482,935 | 1.00 |
| 498 | ARCT | Arcturus Therapeutics Holdings Inc. | 434.59M | 3.80% | 596,188 | 29.37M |
| 499 | AVIR | Atea Pharmaceuticals, Inc. | 426.69M | 0.19% | 272,760 | - |
| 500 | CCCC | C4 Therapeutics, Inc. | 421.98M | -2.28% | 1,485,661 | 35.04M |